Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder

Clinical trial NCT01888107 · COMPLETED

Trial details

NCT number: NCT01888107
Sponsor: Janssen-Cilag S.p.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2005-01-01
Primary completion: 2007-04-01
Enrollment: 347

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.